A petition can affect the path toward a competing medicine without establishing that approval should wait. FDA’s November 8, 2016 rule addresses that mechanism for qualifying petitions: delay requires the agency’s determination that it is necessary to protect public health. Removing an automatic inference from filing to delay is not the same as guaranteeing market entry. [2016-26912][2011-33622]

The January 3, 2012 proposal explained this approach for pending abbreviated new drug applications and the 505(b)(2) pathway. Its account of written petitions and public-health review makes the competitive question concrete: a challenge must be considered through specified procedures rather than treated as sufficient reason for a hold. The proposal is context, not the final operative text. [2016-26912][2011-33622]

The final rule, effective January 9, 2017, includes qualifying petitions concerning certain section 351(k) biologics applications. It incorporates 150-day response language for section 505(q) petitions following statutory changes; the earlier framework described 180 days. That response period does not establish an approval date, a pharmacy stocking date or a lower price for patients. [2016-26912][2011-33622]

In this November 13 retrospective, the market thesis is limited: reducing improper procedural delay is an agency objective, with a public-health exception preserving legitimate scrutiny. Whether access or competition improved would require different evidence. Both retained documents arise from the same FDA rulemaking, not independent corroboration. Neither measures additional entrants, consumer savings or actual availability resulting from these procedural changes. [2016-26912][2011-33622]

Source documents

  1. Amendments to Regulations on Citizen Petitions, Petitions for Stay of Action, and Submission of Documents to Docketshttps://www.govinfo.gov/content/pkg/FR-2016-11-08/html/2016-26912.htm
  2. Amendments to Regulations on Citizen Petitions, Petitions for Stay of Action, and Submission of Documents to Docketshttps://www.govinfo.gov/content/pkg/FR-2012-01-03/html/2011-33622.htm